글로벌 감염성 질환 시장 – 2031년까지의 산업 동향 및 예측

감염성 질환 시장 분석 및 규모

감염성 질환 시장, 특히 박테리아 감염과 관련하여 항생제 내성 균주의 증가로 인해 신속한 진단 및 효과적인 치료에 대한 수요가 급증하고 있습니다. Cepheid 및 Tetraphase Pharmaceuticals와 같은 회사는 각각 혁신적인 테스트 플랫폼과 새로운 항생제를 개발하여 이러한 추세를 활용하고 있습니다. 이는 박테리아 감염에 맞서기 위한 고급 솔루션에 대한 시장 수요가 증가하고 있음을 나타내며, 이 분야에서 투자와 혁신을 촉진합니다.

글로벌 감염병 시장 규모는 2023년에 205억 2천만 달러로 평가되었으며, 2031년까지 321억 4천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 5.77%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화       

시장 정의

감염성 질환은 박테리아, 바이러스, 진균 또는 기생충과 같은 유해한 세균에 의해 발생하는 질병입니다. 이러한 세균은 직접 접촉, 오염된 음식이나 물, 심지어 공기를 통해 사람 간에 쉽게 퍼질 수 있습니다. 일반적인 사례로는 독감, 감기, 결핵, COVID-19가 있습니다. 예방 접종, 적절한 위생, 아픈 사람과의 긴밀한 접촉을 피하는 것과 같은 예방 조치는 확산을 통제하는 데 중요합니다.

감염성 질환 시장 동향

운전자

• 빠른 진단 솔루션에 대한 수요 증가

감염병 시장에서는 신속한 진단 솔루션에 대한 수요가 증가하는 것이 주요 동인인데, 감염을 적시에 탐지하고 관리하는 데 중요한 역할을 하기 때문입니다. 신속한 검사를 통해 의료 서비스 제공자는 질병을 신속하게 진단하여 신속한 치료 시작과 예방 조치 시행을 용이하게 할 수 있습니다. 이는 발병을 억제하고, 전염률을 최소화하고, 관련 의료 부담을 완화해야 하는 시급한 필요성을 해결합니다. 결과적으로 시장은 이러한 증가하는 수요를 효과적으로 충족하기 위해 혁신과 투자가 급증하고 있습니다. 예를 들어, COVID-19 팬데믹 동안 신속한 항원 검사에 대한 수요가 전 세계적으로 급증했습니다. 이러한 검사는 빠른 결과를 제공하여 감염된 개인을 신속하게 식별하고, 격리 조치를 시행하고, 지역 사회 내에서 바이러스 확산을 통제하는 데 도움이 됩니다.

• 예방 조치에 대한 인식 증가

감염병 시장에서 예방 조치에 대한 인식이 증가함에 따라 적극적인 건강 행동을 촉진하고 질병 전파를 줄이고 있습니다. 교육 이니셔티브와 함께 강화된 대중 인식 캠페인은 개인이 예방 접종, 손 위생 및 위생 관행과 같은 예방 조치를 채택하도록 장려합니다. 이는 질병 발생률과 심각성을 감소시켜 예방 제품 및 서비스에 대한 수요를 촉진하고 전반적으로 더 건강한 인구를 육성합니다.

기회

• 질병 전파에 영향을 미치는 환경 변화

Environmental changes, such as climate change and urbanization, significantly influence disease transmission dynamics. Altered weather patterns and habitat destruction can lead to shifts in vector distribution and increase the spread of vector-borne diseases such as malaria and dengue fever. Additionally, urbanization creates favorable conditions for disease transmission, including overcrowding and inadequate sanitation. These changes drive the emergence and reemergence of infectious diseases, necessitating adaptation strategies and investments in disease surveillance, prevention, and control measures. For instance, rising temperatures and changing precipitation patterns due to climate change have expanded the geographic range of mosquito vectors responsible for diseases such as dengue fever and Zika virus. This has led to increased transmission rates in previously unaffected regions, posing new public health challenges.

• Government Initiatives for Infectious Disease Control

Government initiatives play a crucial role in driving infectious disease control efforts by providing funding, implementing policies, and coordinating responses. Through initiatives such as vaccination campaigns, disease surveillance systems, and public health education, governments aim to prevent, detect, and mitigate the spread of infectious diseases. These efforts not only safeguard public health but also contribute to economic stability by reducing healthcare costs and productivity losses associated with disease outbreaks, fostering a healthier and more resilient population.

Restraints/Challenges

• Poor Sanitation in Developing Regions

Poor sanitation in developing regions for infectious diseases is creating environments for disease transmission. Inadequate access to clean water and sanitation facilities increases the risk of waterborne diseases such as cholera and diarrheal illnesses. In addition, improper waste management leads to the proliferation of vectors such as mosquitoes, contributing to the spread of vector-borne diseases such as malaria and dengue fever. For instance, in areas with poor sanitation infrastructure, such as certain rural communities in sub-Saharan Africa or South Asia, contaminated water sources are common. This leads to frequent outbreaks of waterborne diseases such as typhoid fever, and hepatitis A, affecting public health significantly.

• Economic Constraints Affecting Healthcare Spending

Economic constraints act as a significant restraint in the fight against infectious diseases by limiting the financial resources available for healthcare spending. In regions with constrained budgets, governments and individuals may struggle to afford essential medical supplies, vaccines, and treatments. This can lead to inadequate disease prevention and control measures, hindering efforts to contain outbreaks and resulting in higher morbidity and mortality rates. As a result, infectious diseases disproportionately affect socioeconomically disadvantaged populations, exacerbating existing health disparities.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In January 2023, Thermo Fisher Scientific Inc. launched its CE – IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. This advancement enhances therapeutic efficacy, fosters viral resistance monitoring, and propels innovation within the infectious disease market
• In July 2022, Roche launched Elecsys HCV Duo, an immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCBv) antigen and antibody status form a single human plasma or serum sample. This innovation enhances diagnostic efficiency, expedites patient care, and drives advancements in infectious disease management, fostering market expansion
• In March, 2020, Becton Dickinson and Company (BD) announced the release of a new Rapid Serology Test to identify COVID-19 exposure. The procedure is a new point-of-care test that can identify present or previous exposure to COVID-19 in less than 15 minutes by detecting antibodies in blood. Providing results within 15 minutes, it expedites diagnosis, informs patient management, and bolsters surveillance efforts, catalyzing growth and innovation within the infectious disease market

Infectious Diseases Market Scope

The market is segmented into four notable segments based on product and services, technology, disease type, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Services

• Assays
• Kits and Reagents
• Instruments
• Services
• Software

Technology

• Immunodiagnostics
• Clinical Microbiology
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• DNA Sequencing and Next-Generation Sequencing (NGS)
• DNA Microarray
• Other Technologies

Disease Type

• Hepatitis
• Human Immunodeficiency Virus (HIV)
• Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
• Hospital-Acquired Infections (HAIS)
• Human Papillomavirus (HPV)
• Tuberculosis (TB)
• Influenza
• Other Infectious Diseases

 End User

• Hospital/Clinical Laboratories
• Reference Laboratories
• Physician Offices
• Academic/Research Institutes
• Other End Users

Infectious Disease Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by based on product and services, technology, disease type, and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America dominates the infectious diseases market due to the high prevalence of improved healthcare infrastructure, increasing occurrences of infectious diseases, adoption of advanced technology, and rising number of clinical laboratories.

Asia-Pacific is expected to be the fastest growing region in the infectious disease market due to the rising health awareness among the people and growing demand of advanced medical technology.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The market also provides you with a detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2016-2021.

Competitive Landscape and Infectious Diseases Market Share Analysis

시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• 애벗(미국)
• BD(미국)
• bioMérieux (프랑스)
• Bio-Rad Laboratories Inc. (미국)
• 다나허(미국)
• DiaSorin SpA(이탈리아)
• 메리디안 바이오사이언스 주식회사(미국)
• 퀴델 코퍼레이션(미국)
• 지멘스(독일)
• Thermo Fisher Scientific Inc. (미국)
• 존슨앤존슨프라이빗리미티드(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 세페이드(미국)
• Qiagen(독일)
• 오라슈어 테크놀로지스(미국)

SKU-53759